• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体阳性乳腺癌的临床及病理特征

[Clinical and pathological characteristics of estrogen receptor-positive breast cancer].

作者信息

Song S T

出版信息

Zhonghua Zhong Liu Za Zhi. 1985 Nov;7(6):426-9.

PMID:3836844
Abstract

Estrogen receptor (ER) was measured in 275 samples from 170 patients with breast cancer by dextran-coated charcoal assay. The results showed that the ER positive rate was 51.2%. The ER status of female patients was not related to age or menopause. The positive rate was lowest in AB blood type. The distribution of positive patients in all types was similar to that reported by Japanese authors. The DNA levels of ER positive cancers were relatively lower than those of negative ones. Pathological examination of cancer tissue indicated that ER positive cancer is well differentiated. The 3 year disease-free rate and 4 year survival rate are both high in ER positive patients than that in the negative patients. Knowledge of ER status is helpful in planning the treatment of breast cancer.

摘要

通过葡聚糖包被活性炭分析法对170例乳腺癌患者的275份样本进行了雌激素受体(ER)检测。结果显示,ER阳性率为51.2%。女性患者的ER状态与年龄或绝经无关。AB血型患者的阳性率最低。所有血型中阳性患者的分布与日本作者报道的相似。ER阳性癌症的DNA水平相对低于阴性癌症。癌组织的病理检查表明,ER阳性癌症分化良好。ER阳性患者的3年无病生存率和4年生存率均高于阴性患者。了解ER状态有助于规划乳腺癌的治疗。

相似文献

1
[Clinical and pathological characteristics of estrogen receptor-positive breast cancer].雌激素受体阳性乳腺癌的临床及病理特征
Zhonghua Zhong Liu Za Zhi. 1985 Nov;7(6):426-9.
2
Pattern of metastases in human breast carcinoma in relation to estrogen receptor status.人类乳腺癌转移模式与雌激素受体状态的关系。
Anticancer Res. 1986 Jan-Feb;6(1):107-11.
3
Estradiol receptor activity in human breast cancer, disease free interval and survival time.人乳腺癌中的雌二醇受体活性、无病间期和生存时间。
Anticancer Res. 1982 Jan-Apr;2(1-2):33-6.
4
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer.雌激素受体(ER)和人表皮生长因子受体2(HER2)蛋白的共表达类型作为预测ER阳性和HER2阳性乳腺癌患者抗雌激素治疗耐药性的一个因素。
Oncol Rep. 2005 Nov;14(5):1109-16.
5
[Factors affecting estrogen and progesterone receptors in primary breast cancer].
Gan No Rinsho. 1983 May;29(6):621-7.
6
[Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations].[局部区域性乳腺癌中的雌二醇和孕酮受体。临床与预后相关性]
Sem Hop. 1984 Jan 19;60(2):91-6.
7
Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.通过配体结合试验评估雌激素受体状态在接受保乳手术和放射治疗的早期乳腺癌患者中的预测价值。
Oncol Rep. 2002 Mar-Apr;9(2):375-8.
8
Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.血清雌酮水平与绝经后日本女性雌激素受体阳性乳腺癌风险的关联。
Clin Cancer Res. 2003 Jun;9(6):2229-33.
9
Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.根据雌激素受体和HER2状态,细胞角蛋白-19 mRNA阳性循环肿瘤细胞在早期乳腺癌中的不同预后价值。
J Clin Oncol. 2007 Nov 20;25(33):5194-202. doi: 10.1200/JCO.2007.11.7762. Epub 2007 Oct 22.
10
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.使用新型兔单克隆抗体SP1对乳腺癌雌激素受体进行免疫组织化学检测,在预测生存率方面优于小鼠单克隆抗体1D5。
J Clin Oncol. 2006 Dec 20;24(36):5637-44. doi: 10.1200/JCO.2005.05.4155. Epub 2006 Nov 20.